The Chronobiotic Catalyst: Melatonin in the Promotion of Health (Second Edition)
For decades, melatonin was misunderstood merely as a simple “sleep hormone.” Modern chronobiology and endocrinology have revealed it to be a master regulatory molecule with profound systemic effects ranging from potent antioxidant activity to immunomodulation. Melatonin in the Promotion of Health (Second Edition) is the definitive, fiercely scientific treatise on the pleiotropic effects of melatonin. This volume provides the exact blueprints required by clinicians and researchers to understand the therapeutic potential of melatonin in treating sleep disorders, neurodegenerative diseases, and modulating the aging process.
Mastering Chronobiology and Systemic Effects
The core philosophy of this text is translating the complex endocrinology of the pineal gland into actionable clinical practice. The authors aggressively detail the biosynthesis and receptor pharmacology of melatonin. It dictates exactly how circadian rhythm disruption (often caused by modern artificial lighting) contributes to metabolic syndrome and cognitive decline. It provides the crucial biochemical evidence for melatonin’s role as a potent free radical scavenger, protecting mitochondrial DNA from oxidative damage.
Navigating Therapeutic Applications and Clinical Trials
The book provides a masterclass in the evidence-based clinical application of exogenous melatonin. It dictates the exact clinical pathways for dosing melatonin in the treatment of delayed sleep phase syndrome (DSPS), jet lag, and pediatric sleep disorders (especially in children with autism or ADHD). It provides exhaustive reviews of emerging clinical trials investigating melatonin as an adjunctive therapy in oncology, its neuroprotective role in Alzheimer’s disease models, and its potential to mitigate the toxic effects of chemotherapy.
Frequently Asked Questions (FAQs)
Does this book address pediatric specifically?
While covering all age groups, it features critical chapters on the use of melatonin in pediatric populations, detailing the safety profile, dosing guidelines, and its efficacy in neurodevelopmental disorders.
Who is the primary audience?
It is the absolute, mandatory reference for Endocrinologists, Sleep Medicine Specialists, Neurologists, Pediatricians, and Basic Science Researchers in chronobiology.
